№ lp_2_1_15696
File format: docx
Character count: 144107
File size: 1079 KB
Statistical epidemiologic surveillance report presenting detailed tables on HIV diagnoses, persons living with HIV, deaths, demographic characteristics, exposure modes, geographic distribution, trends, rates, and stages of care in Massachusetts.
Year:
2023
Publication Date:
September 2023
Data Current As Of:
1/1/2023
Geographic Scope:
Massachusetts, United States
Region / City:
Statewide with breakdowns by Health Service Region, county, and select cities
Issuing Agency:
Massachusetts Department of Public Health
Bureau:
Bureau of Infectious Disease and Laboratory Sciences
Document Type:
Epidemiologic surveillance report
Subject:
HIV infection diagnoses, prevalence, mortality, and care continuum
Population Covered:
Individuals diagnosed with HIV infection in Massachusetts
Time Period Covered:
2012–2021 (trends); 2019–2021 (diagnoses and deaths); status as of December 31, 2021
Data Source:
MDPH Bureau of Infectious Disease and Laboratory Sciences
Contact Information:
Jamaica Plain Campus/State Public Health Laboratory, 305 South Street, Jamaica Plain, MA 02130
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Hong Kong
Topic:
Consultancy Invitation
Document Type:
Notice
Organization:
Works Bureau
Author:
N/A
Target Audience:
Consultants in Groups 2 and 3 under the Service Category of Waterworks (WS)
Period of Validity:
From May 2023
Approval Date:
21 February 2023
Amendment Date:
N/A
Year:
2023
Region / city:
Seattle, WA, USA
Topic:
Microbiology, Epidemiology, Infectious Diseases
Document type:
Research Article
Organization / institution:
University of Washington, Fred Hutchinson Cancer Research Center
Author:
Kayla A. Carter, Molly D. Fischer, Mariya I. Petrova, Jennifer E. Balkus
Target audience:
Researchers, Public Health Professionals
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Document type:
Supplementary tables
Subject:
Epidemiology, clinicopathology and diagnostic testing of herpesvirus infections
Species affected:
Domestic goose (Anser anser domestics); Black swan (Cygnus atratus)
Locations:
Lowood; Townsville; Maryborough; Lockyer Valley; Cairns
Dates covered:
15/01/1989–5/01/2021; 14/02/1991 (swan case)
Number of cases:
6
Number at risk:
159 geese; 4 swans
Number dead:
141 geese; 2 swans
Clinical signs:
Lethargy, recumbency, inappetence, vomiting, diarrhoea, tremors, ataxia, open-mouth breathing, rapid death
Gross pathology findings:
Hepatic petechiae and necrosis, splenomegaly, intestinal plaques and haemorrhages, thymic enlargement, pulmonary congestion
Histopathology findings:
Multifocal necrotising hepatitis, splenitis, enteritis, thymitis, vasculitis, eosinophilic intranuclear inclusion bodies
Diagnostic methods:
PCR, virus isolation, electron microscopy, next generation sequencing, serology, microbiology, ELISA
Viruses identified:
Goose herpesvirus (AnHV-2); distinct herpesvirus (AnHV-3)
GenBank accession numbers:
OR578703; OR578701; OR540300; OR578702; OR578704
Comparative tests performed:
Avian Influenza Type A, Newcastle disease virus, DVE, DHV1, pigeon herpesvirus, rotavirus, Salmonella, botulism, heavy metals
Year:
Not specified
Region / City:
Atlanta, Georgia, USA
Subject:
HIV testing and prevention
Document Type:
Survey form
Organization / Institution:
Centers for Disease Control and Prevention (CDC) / ATSDR
Author:
Not specified
Target Audience:
Study participants
Study Period:
Not specified
OMB Control Number:
0920-1357
Expiration Date:
XXXXXXXX
Survey Sections:
Study staff, Participant
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Program:
HIV Care and Treatment Program
System:
CAREWare / CAREAssist
Document type:
Administrative form and confidentiality agreement
Organization:
Oregon Health Authority, Public Health Division, HIV/STD/TB Program
Region:
Oregon
Purpose:
User account addition or deletion and confidentiality acknowledgment
Applicable law:
ORS 179.505; ORS 192.558; ORS 433.008; ORS 433.045; OAR 943 Division 14
Required signatures:
HIV Program Supervisor; IT Representative (when adding a user); Employee
Target users:
Contractors and employees accessing RW CAREWare through OHA
Access scope:
Client-level HIV data and CAREAssist Eligibility Reports
Approval authority:
Oregon Health Authority
Source type:
Official administrative and legal record governing system access and data confidentiality within a public health program
Year:
2025
Region / City:
Global
Theme:
Human rights, HIV response, Trans and gender diverse communities
Document type:
Advocacy submission
Organization / Institution:
Global Action for Trans Equality (GATE)
Author:
Global Action for Trans Equality (GATE)
Target audience:
Policymakers, international health organizations, NGOs
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2025
Region / City:
United Kingdom
Subject:
Viral Hepatitis Management
Document Type:
Clinical Guideline
Author:
Lucy Garvey, Sanjay Bhagani, Ranjababu Kulasegaram, Michael Butler, Emma Hathorn, Paul Randal, Sarah Smith, Ryan White, Rachel Halford, Alison Grant, Giovanni Villa, Subathira Dakshina, Sema Mandal, Dan Bradshaw
Target Audience:
Healthcare professionals in sexual health and infectious diseases
Period of Validity:
2025
Approval Date:
July 21, 2025
Version:
1.2
Version Date:
July 21, 2025
Clinical Commissioning Policy Tenofovir alafenamide for treatment of HIV 1 in adults and adolescents
Year:
2025
Region / City:
England
Theme:
HIV Treatment, Antiretroviral Therapy
Document Type:
Policy Statement
Organization / Institution:
NHS England
Author:
NHS England
Target Audience:
Healthcare professionals, policy makers
Effective Period:
Ongoing from May 2025
Approval Date:
May 2025
Date of Last Update:
August 2025
Year:
2025
Region / City:
Victoria, Australia
Topic:
HIV treatment, healthcare program
Document type:
Official publication
Organization / Institution:
Victorian Government, Department of Health
Author:
Victorian Government
Target audience:
Healthcare professionals, HIV patients, healthcare policy makers
Date of approval:
August 2025
Date of changes:
Not specified
Note:
Year
Contextual Description:
Report on the progress of a training program for healthcare professionals in HIV primary care, focusing on key performance areas such as counseling, testing, patient assessment, and management of mental health and substance abuse in HIV patients.
Year:
2024
Region:
Africa
Document type:
Call for Expression of Interest (EOI)
Issuing organizations:
Africa CDC, Unitaid
Target audience:
Pharmaceutical manufacturers, CDMOs, CROs in Africa
Programmatic focus:
Maternal health, malaria, HIV, and related co-infections
Submission deadline:
August 15, 2024
Question deadline:
July 30, 2024
Issue date:
July 8, 2024
Supported interventions:
Safe Birth Africa project co-funded by European Union
Scope:
Regional manufacturing of therapeutics, diagnostics, and APIs
Product categories:
Oral solid dosage forms, sterile injectables, APIs
Year:
2022
Region / City:
Wisconsin
Topic:
Health Services, HIV Care, Disease Control
Document Type:
Corrective Action Plan
Organization / Institution:
Department of Health Services
Author:
Unknown
Target Audience:
Subrecipients, Healthcare Providers
Period of Implementation:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2017
Region / City:
Atlanta, Georgia
Topic:
HIV Testing in STD Clinics
Document Type:
Interview Guide
Agency:
Centers for Disease Control and Prevention (CDC)
Author:
Unknown
Target Audience:
Clinic managers, healthcare providers involved in HIV testing
Effective Period:
Not specified
Approval Date:
Not specified
Revision Date:
April 25, 2017
Year:
N/A
Region / City:
N/A
Topic:
HIV Diagnosis, HIV Prevention
Document Type:
Survey
Organization / Institution:
CDC
Author:
N/A
Target Audience:
Participants of the GAIN Study
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2021
Region / City:
Pakistan
Topic:
HIV prevention and treatment
Document Type:
Project Document
Organization:
UNDP
Author:
UNDP
Target Audience:
Policy makers, health practitioners, NGOs, key population groups
Period of Activity:
July 2021 - December 2023
Approval Date:
TBC
Amendment Date:
TBC
Year:
2024
Region / City:
Namibia
Topic:
HIV, Human Rights, Health
Document Type:
Report
Organization:
Ministry of Health and Social Services
Author:
Kevin Wessels
Target Audience:
Policymakers, Health Professionals, NGOs, LGBTQI+ Communities
Period of Effect:
2017-2026
Approval Date:
2024
Date of Changes:
N/A
Year:
2023
Region:
Eastern Europe and Central Asia
Topic:
HIV Response, Human Rights, LGBT Rights, Legal Reforms
Document Type:
Report
Author:
ECOM - Eurasian Coalition on Health, Rights, Gender and Sexual Diversity
Target Audience:
Policymakers, Human Rights Organizations, Health Professionals, LGBT+ Community
Period of Implementation:
Ongoing
Date of Approval:
N/A
Date of Changes:
N/A